Country for PR: United Kingdom
Contributor: PR Newswire Europe
Thursday, May 17 2018 - 22:07
Brainomix and Olea Medical Join Forces to Revolutionise Stroke Imaging With the e-STROKE SUITE
OXFORD, England and LA CIOTAT, France, May 17, 2018 /PRNewswire-AsiaNet/ --

e-STROKE SUITE is the complete decision support software for the assessment of 
CT and MR scans of ischemic stroke patients  
Brainomix, based in Oxford, UK and Olea Medical, based in La Ciotat, France 
have joined forces to launch the e-STROKE SUITE. e-STROKE SUITE is the most 
complete imaging solution for stroke, which will transform how imaging is used 
in the field. It is the most holistic imaging solution available anywhere for 
clinical use, and integrates Artificial Intelligence (AI) algorithms, 
proprietary Bayesian post-processing methods and big data to support the 
assessment of plain CT, CT Angiography (CTA) and CT/MR perfusion scans.

     (Logo: )

     (Logo: )

Core components of the e-STROKE SUITE include e-ASPECTS and Olea Sphere(R) 
which are medical imaging solutions developed by the two companies that are 
already in use in hospitals around the world. The e-STROKE SUITE offering also 
includes the e-CTA software solution recently launched by Brainomix.

Brainomix started as a spin-off from the University of Oxford in 2010 and has 
evolved into a world-leading, AI-based medical imaging software company 
dedicated to improving outcomes of patients with neurological and 
cerebrovascular disorders. Brainomix's clinically validated and proprietary 
software solutions are used in routine clinical practice at leading stroke 
centers in more than 16 countries worldwide with plans to expand further during 

Olea Medical has established a strong credibility in stroke management, through 
the introduction of cutting-edge technologies, and partnerships with leading 
institutions worldwide. With over 100 scientific publications on their 
technology applied to stroke management in clinical practice in over 300 of the 
most prestigious healthcare centers worldwide, Olea Medical is the recognized 
leader in standardized, vendor-neutral, advanced quantitative and qualitative 
image post-processing.

Dr. Michalis Papadakis, Brainomix CEO, stated: "Today we announce to the stroke 
community what we believe to be a significant milestone for stroke imaging. 
What brings the two companies together is a common vision of improving lives of 
stroke patients by providing state-of-the-art imaging technology. Our new 
e-STROKE SUITE acts as a standardized and fast decision support tool to help 
physicians choose an appropriate treatment based on the quantitative analysis 
of plain CT, CTA and CT/MR perfusion scans."

"Ten years ago, Olea was created with one main mission: improve diagnosis for 
life," said Faycal Djeridane, Olea Medical CEO. "Stroke was, at that time, our 
main concern. It is now one of our major priorities. Today, along with our 
innovative approach in advanced post-processing, we are happy to join forces 
with Brainomix to offer doctors the most outstanding technologies for the 
utmost benefit of patients all over the world. I trust this partnership will 
make a significant difference in patient care and bring new hope to those who 
struggle with this severe condition."

Professor Istvan Szikora, Interventional Neuroradiologist at the National 
Institute of Neurosciences in Hungary stated, "Clinical practice in stroke 
requires a single imaging workflow that can speed up and standardize 
interpretation of CT, CTA and CT/MR perfusion scans to assist  fast and 
accurate decision making. It is essential that imaging software solutions can 
support this workflow and are applied not only in the comprehensive stroke 
centres but also in the whole network of referring hospitals. Such solutions 
should come under a single software package and we are therefore watching with 
great enthusiasm and optimism the joint effort of Brainomix and Olea Medical, 
two leading companies in the field of medical imaging software for stroke, to 
launch the e-STROKE SUITE."

About Brainomix:

Brainomix, a medical diagnostics software company, was founded in 2010 as a 
spin-out from the University of Oxford and is dedicated to improving outcomes 
for patients with neurological and cerebrovascular disorders. Brainomix is 
currently focusing on acute stroke. By developing and equipping physicians with 
world-class, artificial intelligence-based medical imaging software, Brainomix 
aims to help them in making life-saving treatment decisions by supporting the 
selection of the right treatment for the right stroke patient.

For more information, please visit

About Olea:

Olea Medical(R), a Canon Medical Systems Corporation company, is a provider of 
advanced MR and CT imaging post-processing solutions. Based in La Ciotat, 
France, it designs and markets Olea Sphere(R), a suite of innovative medical 
imaging applications that significantly improve diagnosis and monitoring. The 
company has built up its credibility through the domestication of cutting-edge 
technology, and partnerships with leading institutions worldwide. With 
proprietary Bayesian algorithms and optimization methods applied to medical 
imaging, Olea Medical(R) is today a key player in standardized, vendor-neutral, 
advanced MR quantitative and qualitative image post-processing. Covering both 
morphologic and functional imaging, Olea Medical(R) post-processing solutions 
bring complex mathematics into clinical practice for easy access to accurate 
and robust biomarkers and for enhanced diagnostic confidence and 
response-to-treatment assessment.

For more information, please visit

SOURCE: Brainomix and Olea Medical